Brief: Avai Bio, Ainnova Tech terminate JV, license agreement on May 7, 2026 - SEC Filing
08/05/2026 21:40
May 8 (Reuters) - Avai Bio Inc AVAI.PK: AVAI BIO INC - CO AND AINNOVA TECH MUTUALLY TERMINATE JOINT VENTURE AND LICENSE AGREEMENT ON MAY 7, 2026 - SEC FILING AVAI BIO INC - AI-NOVA ACQUISITION CORP. TO BE FORMALLY DISSOLVED - SEC FILING Source text: [ID:n0001740797-26-000011] Further company coverage: AVAI.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avai Bio
See all newsBrief: Avai Bio, Ainnova Tech terminate JV, license agreement on May 7, 2026 - SEC Filing
Brief: Avaí Bio And Austrianova Begin Production Of Master Cell Bank For Klotho Anti-Aging Therapy Under Gmp Standards
Brief: Avant Technologies And JV Partner, Ainnova, Prepare For Key FDA Milestone With Next Week's Pre-Submission Meeting
Brief: Avant Technologies Signs Letter Of Intent For A Business Combination
Brief: Avant Technologies And Ainnova Tech Begin Acquisition Talks